Impact of Chronic GVHD on Patient and Caregiver Experiences in the United States: A Retrospective Social Media Analysis

Researchers from Roswell Park, the Meredith A. Cowden Foundation, Sanofi, and Memorial Sloan Kettering have demonstrated that chronic graft-versus-host disease (GVHD) creates major physical, psychological, social, and financial burden for patients and caregivers in the United States. Published in Transplantation and Cellular Therapy, the study found that online conversations centered on skin involvement, dry eyes, fatigue, pain, gastrointestinal symptoms, and high care costs, among other significant issues. Overall, the authors suggest that chronic GVHD remains life-altering beyond organ-specific clinical measures.

Patients and caregivers often share candid experiences online, offering real-world insights that may be missed by trials, surveys, or standard patient-reported outcome tools. Therefore, the authors performed a retrospective social media listening study of public U.S. posts from September 1, 2022, to September 1, 2024, across X, Reddit, Instagram, Facebook, TikTok, YouTube, forums, blogs, and podcasts. Search terms captured GVHD, chronic GVHD, and treatment-related language; posts from health care professionals, advocacy groups, news/media sources, and likely acute GVHD discussions were excluded. Machine analytics, natural language processing, AI-assisted qualitative analysis, and netnographic review identified themes.

In total, 12,476 posts were captured, of which 5,051 posts from 2,920 unique authors formed the core analytic set with 1,278 posts from 378 authors selected for qualitative analysis. In the qualitative set, 71% of posts were from patients, 15% from caregivers of pediatric patients, and 4% from caregivers of adults. Physical, mental, or emotional burden appeared in 78% of qualitative posts, with physical burden in 50%, mental burden in 23%, and emotional burden in 21%. In the core set, organ manifestations appeared in 43% of posts, specific treatments in 24%, and logistical or financial burden in 7%; inability to work was the most common issue. Treatments were discussed in 42% of qualitative posts, and possible side effects in 27%. The authors conclude that improved treatments, specialist care, mental health support, and financial resources are needed to reduce chronic GVHD burden.

Reference: 

Holtan S, Cowden M, Derrien-Connors C, Marshall K, Preblick R, Perales MA. Impact of Chronic GVHD on Patient and Caregiver Experiences in the United States: A Retrospective Social Media Analysis. Transplant Cell Ther. Published online May 9, 2026. http:doi.org/10.1016/j.jtct.2026.05.001